BWAY

Brainsway Ltd ADR

10.11

Nov 13 • 3:59 PM ET -0.14 (-1.37%)

10.11

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Medical Devices Israel Small NASD

Peers: STIM LIVN NPCE ECOR MDT NXL CLPT INSP BSX CMPS

| Held by: IZRL ITEQ APIE IBRN ASD

Scroll to Statements

Index	-
Market Cap	406.93M
Enterprise Value	350.38M
Income	10.14M
Sales	65.52M
Book/sh	2.04
Cash/sh	1.58
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	129
IPO	Apr 17, 2019

P/E	41.13
Forward P/E	20.22
PEG	0.47
P/S	6.21
P/B	4.95
P/C	6.42
P/FCF	31.47
EV/EBITDA	32.84
EV/Sales	5.35
Quick Ratio	2.62
Current Ratio	2.89
Debt/Eq	0.08
LT Debt/Eq	0.07
Option/Short	Yes / Yes

EPS (ttm)	0.25
EPS next Y	0.50
EPS next Q	0.09
EPS this Y	62.96%
EPS next Y	70.45%
EPS next 5Y	43.33%
EPS past 3/5Y	- -
Sales past 3/5Y	24.82% 18.84%
EPS Y/Y TTM	52.46%
Sales Y/Y TTM	32.47%
EPS Q/Q	19.81%
Sales Q/Q	32.56%
Earnings	Nov 10 BMO
EPS/Sales Surpr.	-42.33% 1.96%

Insider Own	26.41%
Insider Trans	0.00%
Inst Own	16.31%
Inst Trans	0.15%
ROA	8.48%
ROE	13.31%
ROIC	11.53%
Gross Margin	76.06%
Oper. Margin	13.63%
Profit Margin	15.47%
SMA20	-10.26%
SMA50	-17.52%
SMA200	-27.12%
Trades

Shs Outstand	40.25M
Shs Float	29.62M
Short Float	0.67%
Short Ratio	1.86
Short Interest	0.20M
52W High	17.40 -41.90%
52W Low	7.14 41.70%
Volatility	8.08% 4.91%
ATR (14)	0.70
RSI (14)	37.45
Beta	1.36
Rel Volume	1.72
Avg Volume	107.12K
Volume	183,705

Perf Week	-9.33%
Perf Month	-14.47%
Perf Quarter	-34.73%
Perf Half Y	-32.73%
Perf YTD	6.31%
Perf Year	26.30%
Perf 3Y	413.20%
Perf 5Y	154.50%
Perf 10Y	-
Recom	1.00
Target Price	19.27
Prev Close	10.25
Price	10.11
Change %	-1.37%

Consensus

Strong Buy

Avg. Price Target

$19.27

Implied Upside

+90.6%

Analysts8incl. previous ratings

Rating Distribution7 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jul 20, 2026	Initiated	BBTIG Research	Buy	$18	+78.0%
Nov 16, 2023	Downgrade	RRaymond James	Outperform → Mkt Perform
Mar 03, 2022	Initiated	LLoop Capital	Buy	$15	+48.4%
Jul 19, 2021	Initiated	HH.C. Wainwright	Buy	$17	+68.2%
Apr 20, 2021	Initiated	NNorthland Capital	Outperform	$15	+48.4%
May 13, 2019	Initiated	RRaymond James	Outperform	$14	+38.5%
May 13, 2019	Initiated	OOppenheimer	Outperform
May 13, 2019	Initiated	LLadenburg Thalmann	Buy
May 13, 2019	Initiated	CCantor Fitzgerald	Overweight	$17	+68.2%

Nov-10-26 10:49AM	BrainsWay Misses On EPS, But Margin Expansion And A Swelling Backlog Make The Shortfall Look Like Noise In A Stock Priced For Trouble (Earnings Whispers) -8.33%
07:30AM	BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights (GlobeNewswire)
Nov-02-26 11:57PM	BrainsWay's Q3 Test: Can Record Growth Win Back A Stock Down 30%? (Earnings Whispers)
07:30AM	BrainsWay Announces Strategic Collaboration with Mindful Health Solutions (GlobeNewswire)
Oct-28-26 08:00AM	BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026 (GlobeNewswire)
07:30AM	Loading…
Oct-26-26 07:30AM	BrainsWay Expands U.S. Insurance Coverage for Deep TMS Treatment of OCD to Over 118 Million Lives (GlobeNewswire)
Oct-19-26 07:30AM	BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group (GlobeNewswire)
Oct-13-26 07:30AM	BrainsWay Reports Rise in Favorable Accelerated Deep TMS Coverage to Over 70 Million Covered Lives (GlobeNewswire)
Sep-08-26 07:30AM	BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer's Disease Treated with Deep TMS (GlobeNewswire)
Aug-27-26 07:30AM	BrainsWay Deep TMS Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation (GlobeNewswire)
Aug-12-26 07:03PM	BrainsWay Ltd (BRSYF) (Q2 2026) Earnings Call Highlights: Revenue Surges 35% to $17. ... (GuruFocus.com) +10.81%
07:30AM	BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights (GlobeNewswire)
Aug-11-26 09:20AM	Earnings To Watch: BrainsWay Ltd (BWAY) Q2 2026 -- GF Value Sees 35% Downside (GuruFocus.com)
Jul-29-26 07:30AM	BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026 (GlobeNewswire) -8.59%
Jul-20-26 07:30AM	BrainsWay Announces Strategic Investment in Radial Health, Inc. (GlobeNewswire)
07:30AM	Loading…
Jul-16-26 07:30AM	BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral (GlobeNewswire)
Jun-29-26 07:30AM	BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS in Patients with Comorbid PTSD and Major Depressive Disorder (GlobeNewswire)
Jun-22-26 07:30AM	BrainsWay Reports Favorable Coverage for Accelerated Deep TMS Rises to Over 57 Million Covered Lives (GlobeNewswire)
Jun-09-26 07:30AM	BrainsWay Presents First SWIFT Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting (GlobeNewswire)
May-18-26 07:30AM	BrainsWay Announces Minority-Stake Investment in Hopemark Health (GlobeNewswire)
May-13-26 07:02PM	BrainsWay Ltd (BRSYF) Q1 2026 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
07:30AM	BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights (GlobeNewswire)
Apr-29-26 08:00AM	BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026 (GlobeNewswire)
Apr-15-26 07:30AM	BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy (GlobeNewswire) +5.61%
Apr-14-26 08:02PM	Are Medical Stocks Lagging Alcon (ALC) This Year? (Quartz)
Apr-13-26 08:03PM	Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why (Quartz)
08:00AM	BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-26-26 07:30AM	BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of ProlivRx System for MDD (GlobeNewswire)
Mar-19-26 07:30AM	BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health (GlobeNewswire)
Mar-11-26 03:01PM	BrainsWay Ltd (BRSYF) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances (GuruFocus.com) +8.34%
07:30AM	Loading…
07:30AM	BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights (GlobeNewswire)
Mar-10-26 09:24AM	Earnings To Watch: BrainsWay Ltd (BWAY) Reports Q4 2025 Result (GuruFocus.com)
Mar-05-26 09:30AM	Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion (PR Newswire)
Mar-04-26 07:30AM	Landmark Data Validate BrainsWay's SWIFT Deep TMS, Beginning a New Era in Depression Treatment (GlobeNewswire) +7.42%
Feb-25-26 08:00AM	BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026 (GlobeNewswire)
Feb-23-26 08:00AM	BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day (GlobeNewswire)
Feb-19-26 07:30AM	BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc. (GlobeNewswire) -8.22%
Feb-18-26 07:30AM	BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care (GlobeNewswire)
Feb-17-26 07:30AM	BrainsWay Announces Change in ADS-to-Ordinary Share Ratio (GlobeNewswire) +8.61%
Jan-21-26 07:30AM	BrainsWay Announces Draft Coverage Policy from Highmark for Accelerated Deep TMS (GlobeNewswire)
Jan-12-26 07:30AM	BrainsWay Announces FDA Approval of Neurolief's ProlivRx Neuromodulation System for Major Depressive Disorder (MDD) (GlobeNewswire)
Jan-07-26 07:30AM	BrainsWay Announces First Coverage Policy for Accelerated Deep TMS (GlobeNewswire)
Dec-23-25 12:07PM	BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens (Zacks)
Dec-22-25 07:30AM	BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS (GlobeNewswire) +10.05%
Dec-02-25 10:12AM	Are Options Traders Betting on a Big Move in BrainsWay Stock? (Zacks)
Nov-25-25 07:30AM	BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS Treatment December 1, 2025 (GlobeNewswire)
Nov-17-25 07:30AM	BrainsWay Launches First Clinical Trial of Deep TMS 360 System for Alcohol Use Disorder (GlobeNewswire)
Nov-13-25 06:00AM	BrainsWay Receives FDA Clearance of Deep TMS as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 (GlobeNewswire)
Nov-11-25 04:01PM	BrainsWay Ltd (BWAY) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) -5.83%
07:30AM	BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights (GlobeNewswire)
Nov-10-25 07:21AM	What To Expect From BrainsWay Ltd (BWAY) Q3 2025 Earnings (GuruFocus.com)
Nov-07-25 09:40AM	Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? (Zacks)
Nov-04-25 08:00AM	BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder (GlobeNewswire)
Oct-28-25 09:15AM	Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? (Zacks)
08:00AM	BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025 (GlobeNewswire)
Oct-27-25 07:30AM	BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers (GlobeNewswire)
Oct-21-25 09:40AM	Are Medical Stocks Lagging Alkermes (ALKS) This Year? (Zacks)
08:28AM	MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy (Business Wire)
Sep-26-25 01:29PM	Do Options Traders Know Something About Brainsway Stock We Don't? (Zacks)
Sep-17-25 10:41AM	BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care (Zacks)
Sep-16-25 08:30AM	BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD) (GlobeNewswire) +11.89%
Aug-22-25 01:30PM	BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care (Zacks)
Aug-21-25 09:32AM	Neurolief Prepares for Launch of its ProlivRx System for Major Depressive Disorder with Strategic Investment from BrainsWay (PR Newswire)
07:30AM	BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd. (GlobeNewswire)
Aug-20-25 09:15AM	Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? (Zacks)
07:30AM	BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health (GlobeNewswire)
Aug-19-25 09:40AM	Are Medical Stocks Lagging Biotricity (BTCY) This Year? (Zacks)
09:15AM	Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-18-25 12:20PM	Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock (Zacks) +14.41%
09:55AM	Wall Street Analysts Think Brainsway (BWAY) Could Surge 25.58%: Read This Before Placing a Bet (Zacks)
Aug-13-25 07:30AM	BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights (GlobeNewswire)
Aug-12-25 09:25AM	Earnings To Watch: BrainsWay Ltd (XTAE:BWAY) Reports Q2 2025 Result (GuruFocus.com)
Jul-30-25 09:02AM	BrainsWay Champions TMS Education with Sponsorship of Two Free CME Courses for Mental Health Professionals (GlobeNewswire)
08:00AM	BrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025 (GlobeNewswire)
Jul-22-25 08:07AM	Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns (Zacks)
Jul-15-25 08:50AM	Here's What Could Help Brainsway (BWAY) Maintain Its Recent Price Strength (Zacks)
Jun-26-25 08:36AM	Is the Options Market Predicting a Spike in Brainsway Stock? (Zacks) +6.24%
Jun-24-25 09:55AM	Wall Street Analysts Believe Brainsway (BWAY) Could Rally 30.98%: Here's is How to Trade (Zacks) +6.70%
08:54AM	Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength? (Zacks)
Jun-19-25 09:40AM	Are Medical Stocks Lagging Brainsway (BWAY) This Year? (Zacks)
Jun-12-25 09:15AM	Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jun-11-25 07:30AM	BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD) (GlobeNewswire)
Jun-10-25 08:50AM	Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
08:00AM	BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego (GlobeNewswire)
Jun-05-25 09:55AM	Does Brainsway (BWAY) Have the Potential to Rally 43.88% as Wall Street Analysts Expect? (Zacks)
Jun-04-25 07:30AM	BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC (GlobeNewswire)
May-29-25 12:20PM	Earnings Estimates Moving Higher for Brainsway (BWAY): Time to Buy? (Zacks)
May-20-25 09:55AM	Wall Street Analysts See a 41.31% Upside in Brainsway (BWAY): Can the Stock Really Move This High? (Zacks)
May-13-25 07:30AM	BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights (GlobeNewswire) +11.10%
May-12-25 09:31AM	BrainsWay Ltd (XTAE:BWAY) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
May-01-25 08:00AM	BrainsWay to Showcase Deep TMS at the 2025 American Psychiatric Association Annual Meeting in Los Angeles (GlobeNewswire)
Apr-29-25 08:00AM	BrainsWay to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Apr-02-25 03:26PM	BrainsWay: Strong Growth Prospects Matter Little To The Market (Seeking Alpha)
Mar-18-25 03:04PM	Steris Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
Mar-12-25 03:03AM	BrainsWay Ltd (BRSYF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +7.07%
Mar-11-25 07:30AM	BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights (GlobeNewswire)
Mar-04-25 08:00AM	BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Feb-24-25 08:00AM	BrainsWay to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 (GlobeNewswire) -9.02%
Feb-17-25 09:15AM	Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue? (Zacks)
Feb-05-25 05:59PM	Outbrain (OB) and Brainsway (BWAY) Are Aggressive Growth Stocks (Zacks)

Show Previous News

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut in 2003 and is headquartered in Jerusalem, Israel.

Chief Executive OfficerMr. Hadar Levy

Co-Founder & Vice-ChairmanDr. David Zacut M.D.

Co-FounderProf. Abraham Zangen Ph.D.

Chief Financial OfficerMr. Ido Marom

Chief Technology OfficerMr. Gilead Moiseyev Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

BWAY

Brainsway Ltd ADR

Upgrade your Finviz experience

All the Features.
Half the Price.